Breaking News
Get 40% Off 0
⌛ Did you miss ProPicks’ 13% gains in May? Subscribe now & catch June’s top AI-picked stocks early. Unlock Stocks
Close

AbbVie Inc (ABBV)

Create Alert
New!
Create Alert
Website
  • As an alert notification
  • To use this feature, make sure you are signed-in to your account
Mobile App
  • To use this feature, make sure you are signed-in to your account
  • Make sure you are signed-in with the same user profile

Condition

Frequency

Once
%

Frequency

Frequency

Follow AbbVie's earnings

Delivery Method

Status

Add to/Remove from a Portfolio Add to Watchlist
Add to Watchlist
Add Position

Position added successfully to:

Please name your holdings portfolio
 
157.06 -1.20    -0.76%
- Closed. Currency in USD ( Disclaimer )
Pre Market
157.83
+0.77
+0.49%
- Real-time Data
  • Volume: 3,691,730
  • Bid/Ask: 0.00 / 0.00
  • Day's Range: 156.36 - 158.78
Type:  Equity
Market:  United States
AbbVie 157.06 -1.20 -0.76%

AbbVie Company Profile

 
Read the AbbVie company profile to learn more about the business and the management team. View AbbVie Inc facts about employee data, company products and services, and contact information.
IndustryPharmaceuticals
SectorHealthcare
Employees

50000

Equity Type

ORD

AbbVie Inc. discovers, develops, manufactures, and sells pharmaceuticals worldwide. The company offers Humira, an injection for autoimmune and intestinal Behçet's diseases, and pyoderma gangrenosum; Skyrizi to treat moderate to severe plaque psoriasis, psoriatic disease, and Crohn’s disease; Rinvoq to treat rheumatoid and psoriatic arthritis, ankylosing spondylitis, atopic dermatitis, axial spondyloarthropathy, ulcerative colitis, and Crohn's disease; Imbruvica for the treatment of adult patients with blood cancers; Epkinly to treat lymphoma; Elahere to treat cancer; and Venclexta/Venclyxto to treat blood cancers. It also provides facial injectables, plastics and regenerative medicine, body contouring, and skincare products; botox therapeutic; Vraylar for depressive disorder; Duopa and Duodopa to treat advanced Parkinson's disease; Ubrelvy for the acute treatment of migraine in adults; and Qulipta for episodic and chronic migraine. In addition, the company offers Ozurdex for eye diseases; Lumigan/Ganfort and Alphagan/Combigan for the reduction of elevated intraocular pressure in patients with open angle glaucoma or ocular hypertension; Restasis to increase tear production; and other eye care products. Further, it provides Mavyret/Maviret to treat chronic hepatitis C virus genotype 1-6 infection; Creon, a pancreatic enzyme therapy; Lupron to treat advanced prostate cancer, endometriosis and central precocious puberty, and patients with anemia caused by uterine fibroids; Linzess/Constella to treat irritable bowel syndrome with constipation and chronic idiopathic constipation; and Synthroid for hypothyroidism. It has collaborations with Calico Life Sciences LLC; REGENXBIO Inc.; Janssen Biotech, Inc.; and Genentech, Inc., as well as collaboration with Tentarix Biotherapeutics, LP to develop conditionally-active and multi-specific biologics for oncology and immunology. The company was incorporated in 2012 and is headquartered in North Chicago, Illinois.

Contact Information

Address 1 North Waukegan Road
North Chicago, 60064-6400
United States
Phone 847 932 7900
Fax -

Top Executives

Name Age Since Title
Richard A. Gonzalez 67 2013 Chairman & CEO
Edward Joseph Rapp 65 2013 Independent Director
William H. L. Burnside 71 2013 Independent Director
Roxanne S. Austin 62 2013 Independent Director
Glenn F. Tilton 75 2013 Lead Independent Director
Thomas Craig Freyman 69 2020 Independent Director
Robert J. Alpern 72 2013 Independent Director
Frederick H. Waddell 69 2013 Independent Director
Rebecca B. Roberts 70 2018 Independent Director
Melody Boone Meyer 65 2017 Independent Director
Brett J. Hart 53 2016 Independent Director
Susan E. Quaggin 60 2023 Independnet Director
Jennifer L. Davis 52 2023 Independnet Director
Comment Guidelines

We encourage you to use comments to engage with users, share your perspective and ask questions of authors and each other. However, in order to maintain the high level of discourse we’ve all come to value and expect, please keep the following criteria in mind: 

  • Enrich the conversation
  • Stay focused and on track. Only post material that’s relevant to the topic being discussed.
  • Be respectful. Even negative opinions can be framed positively and diplomatically.
  •  Use standard writing style. Include punctuation and upper and lower cases.
  • NOTE: Spam and/or promotional messages and links within a comment will be removed
  • Avoid profanity, slander or personal attacks directed at an author or another user.
  • Don’t Monopolize the Conversation. We appreciate passion and conviction, but we also believe strongly in giving everyone a chance to air their thoughts. Therefore, in addition to civil interaction, we expect commenters to offer their opinions succinctly and thoughtfully, but not so repeatedly that others are annoyed or offended. If we receive complaints about individuals who take over a thread or forum, we reserve the right to ban them from the site, without recourse.
  • Only English comments will be allowed.

Perpetrators of spam or abuse will be deleted from the site and prohibited from future registration at Investing.com’s discretion.

ABBV Price Commentary

Write your thoughts about AbbVie Inc
 
Are you sure you want to delete this chart?
 
Post
Post also to:
 
Replace the attached chart with a new chart ?
1000
Your ability to comment is currently suspended due to negative user reports. Your status will be reviewed by our moderators.
Please wait a minute before you try to comment again.
Thanks for your comment. Please note that all comments are pending until approved by our moderators. It may therefore take some time before it appears on our website.
Alan Ng
Alan Ng Oct 07, 2021 15:45
Saved. See Saved Items.
This comment has already been saved in your Saved Items
Abbv going up again.
tyler dong
tyler dong Sep 01, 2021 16:36
Saved. See Saved Items.
This comment has already been saved in your Saved Items
What is happening to abbvie?
Matous B
Matous B Sep 01, 2021 16:36
Saved. See Saved Items.
This comment has already been saved in your Saved Items
ABBV : FDA requires updated warnings on JAK inhibitors citing increased risks of heart events10:56 am, Wed, Sep. 1, 2021
Oc Masai
Oc Masai Jul 12, 2021 18:33
Saved. See Saved Items.
This comment has already been saved in your Saved Items
Bullish guys
Thusara Dissanayake
Thusara Dissanayake Jan 30, 2016 18:06
Saved. See Saved Items.
This comment has already been saved in your Saved Items
Hi how will be EUR/USD next week
James Macdonald
James Macdonald Jan 30, 2016 18:06
Saved. See Saved Items.
This comment has already been saved in your Saved Items
Cloudy with a chance of rain
 
Are you sure you want to delete this chart?
 
Post
 
Replace the attached chart with a new chart ?
1000
Your ability to comment is currently suspended due to negative user reports. Your status will be reviewed by our moderators.
Please wait a minute before you try to comment again.
Add Chart to Comment
Confirm Block

Are you sure you want to block %USER_NAME%?

By doing so, you and %USER_NAME% will not be able to see any of each other's Investing.com's posts.

%USER_NAME% was successfully added to your Block List

Since you’ve just unblocked this person, you must wait 48 hours before renewing the block.

Report this comment

I feel that this comment is:

Comment flagged

Thank You!

Your report has been sent to our moderators for review
Continue with Google
or
Sign up with Email